EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Neuropathic Corneal Pain after Coronavirus Disease 2019 (COVID-19) Infection

Natalie Shi Qi Wong, Chang Liu, Molly Tzu-Yu Lin, Isabelle Xin Yu Lee, Louis Tong, Yu-Chi Liu iD

Diseases · 09.02.2024 · 12 (2) · 37

DOI: 10.3390/diseases12020037 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Diseases, online erschienen am 09.02.2024. Verfasst von Natalie Shi Qi Wong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Singapore National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This is a case report of a patient with neuropathic corneal pain after coronavirus disease 2019 (COVID-19) infection.

Methods

A previously healthy 27-year-old female presented with bilateral eye pain accompanied by increased light sensitivity 5 months after COVID-19 infection. She was diagnosed with neuropathic corneal pain based on clear corneas without fluorescein staining, alongside the presence of microneuromas, dendritic cells, and activated stromal keratocytes identified bilaterally on in vivo confocal microscopy.

Results

The patient’s tear nerve growth factor, substance P, and calcitonin gene-related peptide levels were 5.9 pg/mL, 2978.7 pg/mL, and 1.1 ng/mL, respectively, for the right eye and 23.1 pg/mL, 4798.7 pg/mL, and 1.2 ng/mL, respectively, for the left eye, suggesting corneal neuroinflammatory status. After 6 weeks of topical 0.1% flurometholone treatment, decreased microneuroma size, less extensive dendritic cells, and reduced tear nerve growth factor and substance P levels were observed. The scores on the Ocular Pain Assessment Survey showed an improvement in burning sensation and light sensitivity, decreasing from 80% and 70% to 50% for both.

Conclusions

Neuropathic corneal pain is a potential post-COVID-19 complication that warrants ophthalmologists’ and neurologists’ attention.

Schlagwörter

Stichwörter der Autor:innen

corneacorneal nervescoronavirus disease 2019neuropathic corneal pain

Autor:innen und Institutionen

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
  • Singapore Eye Research Institute, Singapore 169856, Singapore.
  • Department of Cornea and External Eye Disease, Singapore National Eye Centre, Singapore 168751, Singapore.
  • Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore 169857, Singapore.

ORCID-Profile: Yu-Chi Liu

Förderung

  • Ministry of Health
  • Singapore National Medical Research Council

Zitieren

APA

Wong, N. S. Q., Liu, C., Lin, M. T., Lee, I. X. Y., Tong, L., & Liu, Y. C. (2024). Neuropathic Corneal Pain after Coronavirus Disease 2019 (COVID-19) Infection. Diseases, 12(2), 37. https://doi.org/10.3390/diseases12020037

Vancouver

Wong NSQ, Liu C, Lin MT, Lee IXY, Tong L, Liu YC. Neuropathic Corneal Pain after Coronavirus Disease 2019 (COVID-19) Infection. Diseases. 2024;12(2):37. doi:10.3390/diseases12020037

BibTeX
@article{Wong2024,
  author = {Wong, Natalie Shi Qi and Liu, Chang and Lin, Molly Tzu-Yu and Lee, Isabelle Xin Yu and Tong, Louis and Liu, Yu-Chi},
  title = {Neuropathic Corneal Pain after Coronavirus Disease 2019 (COVID-19) Infection},
  journal = {Diseases},
  year = {2024},
  volume = {12},
  number = {2},
  pages = {37},
  doi = {10.3390/diseases12020037}
}
Kostenlos starten →